Publications
Specialty
Search
Psych Congress Network
10/08/2024
Continuing electroconvulsive therapy (ECT) after an acute ECT series is linked with lower rehospitalization risk compared with not continuing ECT, according to study results published in JAMA Psychiatry.
Oncology
10/08/2024
Sally Lau, MD, discusses results from the phase 1b DeLLphi-303 study which demonstrated that tarlatamab plus a PD-L1 inhibitor exhibited efficacy as a first-line maintenance therapy for patients with extensive-stage small cell lung cancer.
Gastroenterology
10/08/2024
Dr Hirsh Trivedi details how he approaches the diagnosis and management of metabolic-dysfunction associated fatty liver disease (MAFLD, formerly NAFLD) and metabolic associated steatohepatosis (MASH, formerly NASH.)
The Dermatologist
10/07/2024
This precision medicine approach to inflammatory skin disease prioritizes a view of the skin microbiome by utilizing bacteriophage therapy, the viruses that target and destroy specific strains of bacteria, based on individual patient skin swabs instead of broad-spectrum antibiotics.
First Report Managed Care
10/07/2024
The pulmonary arterial hypertension drug market is projected to grow to $11.6 billion by 2032, driven by an increase in pulmonary disorders, advancements in treatment options, and greater awareness of the condition.
Advances in Inflammatory Bowel Disease Network
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.
Oncology
10/07/2024
Based on results from the BLUE-C study, the FDA has approved the Cologuard Plus™ test for patients 45 years and older at average risk for colorectal cancer.
Cancer Care Business Exchange, Journal of Clinical Pathways, Clinical Pathways
10/07/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the economic challenges of precision medicine in health care, including the differences between Medicare and commercial health plans and the logistical challenges of arranging testing.
Pharmacy Learning Network
10/07/2024
In this installment of Talking Therapeutics, we explore whether the novel medication finerenone, which has a demonstrated benefit in patients with kidney disease, can also improve outcomes in patients with HFpEF.
Psych Congress Network
10/07/2024
This video describes therapeutic advancements that aim to improve functional outcomes in people living with schizophrenia.
First Report Managed Care
10/07/2024
Mortality was significantly higher among post-9/11 military veterans with epilepsy who had a traumatic brain injury (TBI) before epilepsy or who experienced a TBI within 6 months of their epilepsy diagnosis, according to a study published online in Epilepsia.
Psych Congress NP Institute
10/07/2024
Test your knowledge with a quick quiz!
EMSWorld
10/07/2024
Due to the state changing providers, Wellpath, a contract health insurance provider for inmates and prisoners, still needs to pay back EMS agencies in Michigan.
Neurology
10/07/2024
Disability progression was no slower in patients with primary progressive multiple sclerosis (MS) treated with anti-CD20 infusion therapies than in untreated patients, according to a study of real-world patients published in Neurology.
The Dermatologist
10/07/2024
A 96-year-old woman presented to the dermatology clinic with a scaly plaque on her left cheek that had been there for many years.
Gastroenterology
10/07/2024
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.
Gastroenterology
10/07/2024
How much do you know about the prevalence of fatty liver disease in the US? Test your knowledge with our quick quiz!
Oncology
10/07/2024
Georgina Long, MD, PhD, discusses 3-year follow-up results from the phase 3 CheckMate 76K trial which demonstrated that adjuvant nivolumab continued to sustain clinical benefit among patients with resected stage IIB/IIC melanoma.
The Dermatologist
10/07/2024
The implementation of a dedicated shelf exam for dermatology can help standardize fourth-year rotations, leveling the playing field for students from less-prestigious medical schools and helping them demonstrate their enthusiasm for our specialty.
The Dermatologist
10/07/2024
Nonablative Alexandrite laser therapy may be an effective method of treating melasma in patients with darker skin types.